Chapter 25
Renal Mass (Case 18)
Azzour Hazzan MD
Case: A 46-year-old woman presents for an evaluation of hematuria and flank pain over the past few days. Her pain is dull without radiation, and she has no associated nausea or vomiting. She denies dysuria or frothy urine. Her father died at age 50 years from an intracranial aneurysm. Her exam is remarkable for elevated BP, distended flanks, and left flank tenderness to palpation.
Differential Diagnosis
Polycystic kidney disease (PCKD) |
Renal cancer |
Acquired cystic kidney disease |
Renal manifestations of tuberous sclerosis and renal angiomyolipoma |
Medullary sponge kidney (MSK) disease |
Speaking Intelligently
Certain factors should be considered when evaluating a patient with a renal mass or renal masses. These include the ultrasonographic characteristics of the mass, the presence of patient-specific risk factors for renal malignancy, and systemic signs and symptoms that suggest specific diseases. For example, a 2-cm renal mass that is cystic in nature on ultrasound with no septations in a 30-year-old patient who is otherwise healthy is most likely a benign cyst and needs no further workup. Conversely, a 5-cm mass with complex features such as calcifications or septations in a 60-year-old patient with a history of anemia, fever, and weight loss is very suggestive of renal cell carcinoma.
PATIENT CARE
Clinical Thinking
• Renal lesions are most often discovered incidentally during abdominal imaging.
• Patients with PCKD usually have a family history of renal insufficiency and are hypertensive.
• Patients with MSK often give a history of nephrolithiasis and UTIs.
• Hamartomas or angiomyolipomas can be part of a systemic syndrome such as tuberous sclerosis.
History
Physical Examination
• Hypomelanotic skin lesions, called ash-leaf spots, can be seen in tuberous sclerosis.
• Rarely, when a renal cancer invades and obstructs the left renal vein, this can result in a left testicular varicocele.
Tests for Consideration
$12 |
|
$676 |
|
$5275 |
Clinical Entities | Medical Knowledge |
Polycystic Kidney Disease |
|
Pφ |
There are two major types of autosomal-dominant PCKD. Autosomal-dominant PCKD type 1 is the most common and most severe, with approximately 50% of affected individuals requiring dialysis by the age of 60 years. It is linked to an abnormal gene on chromosome 16, named PKD1. Autosomal-dominant PCKD type 2 is less common and less severe, and is linked to an abnormal gene on chromosome 4, named PKD2. PKD1 and PKD2 encode the proteins polycystin-1 and polycystin-2, respectively. These proteins are involved in cell-cell and cell-matrix interactions. Mutations in these genes lead to cyst formation through an as-yet-undefined mechanism. |
TP |
Often affected patients present with flank pain, resulting from an infected cyst, hemorrhagic cyst, or nephrolithiasis. Other patients present with renal insufficiency and hypertension. Still others present with extrarenal cystic manifestations. Hepatic cysts can be detected in over one half of cases and are more commonly seen in women and in patients over the age of 40 years. An additional manifestation includes intracranial aneurysms, which tend to cluster in families. |
Dx |
For patients who are older than 15 years and at risk for the disease, the diagnosis is made by demonstrating multiple cysts on sonography. The number of cysts necessary to make a diagnosis depends on the patient’s age. Genetic testing can be considered for patients with equivocal results on sonography or in patients who are younger than 30 years and need a definite diagnosis. |
Tx |
Aggressive treatment of high BP may slow the progression to renal failure. ACE inhibitors are frequently used to lower BP and control proteinuria. If the patient develops complications of chronic kidney disease such as anemia, acidosis, or bone disease, these manifestations should be treated. If these patients reach end-stage renal disease, they can either receive a renal transplant or be placed on dialysis. After they are on renal replacement therapy, some patients require nephrectomy for recurrent urinary cyst infection or hemorrhage. See Cecil Essentials 30. |
Pφ |
Acquired cystic kidney disease is a specific disorder in which renal cysts develop in the kidneys of patients with advanced kidney disease. These cysts have an increased risk of malignant transformation. In acquired cystic kidney disease the cysts are limited to the kidney and not dependent upon the underlying cause of kidney failure, which suggests a local rather than systemic cause of cyst development. The cysts likely develop as a result of progressive nephron loss and compensatory hypertrophy and hyperplasia in the remaining nephrons. When the tubular segment of these hyperplastic nephrons becomes obstructed, cyst development occurs. Activation of proto-oncogenes may lead to malignant transformation. |
TP |
Typically acquired cystic kidney disease is asymptomatic and found incidentally on unrelated imaging. Occasionally patients present with flank pain and fever suggestive of cyst infection, hematuria due to cyst hemorrhage, or systemic signs of malignancy after the development of renal cell carcinoma. |
Dx |
Diagnosis is established through imaging studies. Ultrasound, CT scan, and MRI are all sensitive tests. At the time of diagnosis, patients often have multiple bilateral renal cysts. The cysts are usually <0.5 cm in diameter. |
Tx |
No treatment is necessary for asymptomatic cysts. Nephrectomy is the treatment of choice if these cysts have potential malignant features such as septations or calcifications. Nephrectomy is also indicated if the patient develops recurrent cyst infections, kidney stones, or painful cyst hemorrhage. See Cecil Essentials 30. |
Medullary Sponge Kidney Disease |
|
Pφ |
MSK is caused by a developmental abnormality in the terminal collecting ducts of the kidney. This developmental error is associated with the formation of renal cysts involving the renal medulla, but not the renal cortex. The mechanism of cyst development is not well understood. Although some families seem to have an autosomal-dominant inheritance, there is no evidence of hereditary transmission. |
TP |
Patients with MSK are usually asymptomatic, and their condition is only discovered incidentally during unrelated radiographic testing. When symptoms do occur they can be related to kidney stones, which are more common in this population. |
The diagnosis has historically been made by IVP, but CT scan with contrast has recently proven to be a sensitive alternative. The appearance of a “brush” radiating from the renal calyx is the typical finding. Calcium stones, resulting from urinary stasis, can appear in the renal calyces. Ultrasonography is less specific than IVP but typically reveals a uniformly echogenic corticomedullary junction due to calcium deposits in the affected regions. |
|
Tx |
Treatment is indicated only for UTI and for recurrent stone formation. UTIs are treated with antibiotics directed at the cultured organism. Nephrolithiasis is treated with increased water intake and specific therapy targeted at the underlying metabolic abnormality. |
Renal Cancer |
|
Pφ |
Renal cell carcinoma is a common malignancy arising from the renal tubular epithelium. There are several distinct histologic types. Clear cell is the most common type, accounting for the majority of tumors. It originates from the proximal tubule and is specifically associated with VHL disease. Chromophilic or papillary cell carcinoma is the second most common type, and also originates from the proximal tubule. Chromophobic tumors are less common than clear cell or chromophilic carcinoma, and are thought to arise from the cortical collecting duct. Oncocytomas constitute approximately 5% of renal neoplasms; they are believed to originate from the distal collecting tubule and rarely metastasize. |
TP |
The classic triad of flank pain, abdominal mass, and hematuria is rarely present at the time of diagnosis. Other patients present with fever, weakness, and weight loss, or paraneoplastic syndromes (hypercalcemia or polycythemia). Systemic symptoms at the time of diagnosis are often a sign of advanced disease. |
Dx |
CT scan is the preferred method to evaluate potentially malignant renal masses. It can determine the size of the mass, as well as any possible spread, which will allow staging. Tissue diagnosis is required. |
Treatment of renal cell cancer depends on the stage of the disease. A surgical approach is advised for localized cancers. For patients with a resectable stage I, II, or III tumor, surgery offers the best chance of cure. As opposed to the surgical approach, which is considered curative, systemic therapy with molecularly targeted therapy and immunotherapy are the primary approaches for patients with unresectable or recurrent disease. See Cecil Essentials 30, 57. |
Renal Manifestations of Tuberous Sclerosis and Renal Angiomyolipoma |
|
Pφ |
Renal angiomyolipomas are benign neoplasms. They can occur sporadically or as part of the tuberous sclerosis complex. They are composed of adipose tissue, smooth muscle cells, and blood vessels. When they are found as part of tuberous sclerosis they are usually bilateral and larger, while when they occur sporadically they are usually unilateral and small. |
TP |
Small angiomyolipomas are usually asymptomatic. Larger lesions can rupture and cause flank pain and life-threatening retroperitoneal hemorrhage. Some lesions can become large and impinge upon normal renal tissue, resulting in hypertension and renal failure. |
Dx |
The diagnosis is most often made by CT scan, which shows that the lesion has the density of fat. Patients with angiomyolipomas should be evaluated for undiagnosed tuberous sclerosis. |
Tx |
Treatment is dependent upon the size of the mass. If the lesion is smaller than 4 cm, it can be monitored closely and only resected if the growth rate is rapid, or symptoms such as flank pain or hematuria develop. Surgical resection is divided into renal-sparing surgery and complete nephrectomy. The former includes partial nephrectomy and transcatheter embolization. Complete nephrectomies are performed if the tumor invades local tissues or the renal vein. See Cecil Essentials 30. |
Practice-Based Learning and Improvement: Evidence-Based Medicine
Title
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal-dominant polycystic kidney disease
Authors
Ecder T, Chapman AB, Brosnahan GM, et al.
Institution
University of Colorado School of Medicine
Reference
Am J Kidney Dis 2000;35:427–432
Problem
To determine the optimal medication to use to control hypertension in patients with PCKD
Intervention
Patients with PCKD were randomized to BP control with amlodipine or enalapril.
Outcome/effect
BP control was similar in the two groups, but enalapril significantly reduced the albumin-to-creatinine ratio.
Historical significance/comments
In many forms of renal disease, suppression of proteinuria is a surrogate for improved renal survival. Although further studies are necessary, this gives evidence that ACE inhibitors or ARBs may be the hypertensive medication of choice for patients with PCKD.
Interpersonal and Communication Skills
Demonstrate Empathy When Discussing the Impact of an Inheritable Disease
PCKD is a chronic progressive disease with multiple potential complications. Patients often have affected first-degree relatives who may be on dialysis or who may have died prematurely from cerebral aneurysms. Therefore, it is very important to have a discussion that allows and encourages a patient to openly discuss his or her personal experiences and fears. Such discussions should be conducted privately with the patient, as close family members may not be aware that they are at risk of having PCKD. Parents often do not want their children to know that they are at risk until they are old enough to understand the diagnosis and management.
Professionalism
Assess the Impact on the Individual When Considering Screening
Patients with PCKD commonly ask their nephrologists for recommendations about screening their children for PCKD. Being diagnosed with PCKD at an early age before the development of complications is not medically necessary and may cause the individual unwarranted difficulties. Patients with PCKD have difficulty obtaining life insurance and have to deal with the emotional hardship of being diagnosed with a chronic progressive medical illness. The current recommendation is to not screen asymptomatic children younger than 18 years of age. Individuals older than 18 years who would like to donate a kidney should be screened to avoid transplanting a diseased kidney. In all other asymptomatic individuals at risk, it is advisable to address risk as well as benefits and make an informed decision with the patient. Issues such as insurability and employment must be addressed.
Assessing the Cost-Effectiveness of Screening
Although patients with PCKD are at risk for cerebral aneurysm, it is not cost-effective to screen all patients with PCKD for aneurysms. Aneurysms cluster in families, so it is recommended to screen only those patients with a family history of aneurysm, as well as those individuals who would endanger others if they were to incur the complication of cerebral aneurysm rupture. An individual employed as an airplane pilot would be such an example.